» Articles » PMID: 34390487

Racial and Ethnic Inequities in the Early Distribution of U.S. COVID-19 Testing Sites and Mortality

Overview
Publisher Wiley
Specialty General Medicine
Date 2021 Aug 14
PMID 34390487
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In 2020, early U.S. COVID-19 testing sites offered diagnostic capacity to patients and were important sources of epidemiological data about the spread of the novel pandemic disease. However, little research has comprehensively described American testing sites' distribution by race/ethnicity and sought to identify any relation to known disparities in COVID-19 outcomes.

Methods: Locations of U.S. COVID-19 testing sites were gathered from 16 April to 28 May 2020. Geographic testing disparities were evaluated with comparisons of the demographic makeup of zip codes around each testing site versus Monte Carlo simulations, aggregated to statewide and nationwide levels. State testing disparities were compared with statewide disparities in mortality observed one to 3 weeks later using multivariable regression, controlling for confounding disparities and characteristics.

Results: Nationwide, COVID-19 testing sites geographically overrepresented White residents on 7 May, underrepresented Hispanic residents on 16 April, 7 May and 28 May and overrepresented Black residents on 28 May compared with random distribution within counties, with new sites added over time exhibiting inconsistent disparities for Black and Hispanic populations. For every 1 percentage point increase in underrepresentation of Hispanic populations in zip codes with testing, mortality among the state's Hispanic population was 1.04 percentage points more over-representative (SE = 0.415, p = .01).

Conclusions: American testing sites were not distributed equitably by race during this analysis, often underrepresenting minority populations who bear a disproportionate burden of COVID-19 cases and deaths. With an easy-to-implement measure of geographic disparity, these results provide empirical support for the consideration of access when distributing preventive resources.

Citing Articles

Community utilization of a co-created COVID-19 testing program in a US/Mexico border community.

Reyes B, Calvillo S, Escoto A, Lomeli A, Burola M, Gay L BMC Public Health. 2024; 24(1):3194.

PMID: 39558266 PMC: 11572090. DOI: 10.1186/s12889-024-20527-4.


SARS-CoV-2 serosurvey across multiple waves of the COVID-19 pandemic in New York City between 2020-2023.

Carreno J, Wagner A, Monahan B, Singh G, Floda D, Gonzalez-Reiche A Nat Commun. 2024; 15(1):5847.

PMID: 38992013 PMC: 11239669. DOI: 10.1038/s41467-024-50052-2.


Lessons From COVID-19 Testing Research: The Power of Rapid Response.

Compton W, Hooper M, Hodes R, Perez-Stable E Am J Public Health. 2024; 114(S5):S343-S346.

PMID: 38776500 PMC: 11111383. DOI: 10.2105/AJPH.2024.307653.


Excess Mortality in the United States, 2020-21: County-level Estimates for Population Groups and Associations with Social Vulnerability.

Kandula S, Keyes K, Yaari R, Shaman J medRxiv. 2024; .

PMID: 38293208 PMC: 10827264. DOI: 10.1101/2024.01.14.24301290.


Genetic risk prediction in Hispanics/Latinos: milestones, challenges, and social-ethical considerations.

Maldonado B, Pique D, Kaplan R, Claw K, Gignoux C J Community Genet. 2023; 14(6):543-553.

PMID: 37962783 PMC: 10725387. DOI: 10.1007/s12687-023-00686-4.


References
1.
Millett G, Jones A, Benkeser D, Baral S, Mercer L, Beyrer C . Assessing differential impacts of COVID-19 on black communities. Ann Epidemiol. 2020; 47:37-44. PMC: 7224670. DOI: 10.1016/j.annepidem.2020.05.003. View

2.
Lieberman-Cribbin W, Tuminello S, Flores R, Taioli E . Disparities in COVID-19 Testing and Positivity in New York City. Am J Prev Med. 2020; 59(3):326-332. PMC: 7316038. DOI: 10.1016/j.amepre.2020.06.005. View

3.
Richardson S, Hirsch J, Narasimhan M, Crawford J, McGinn T, Davidson K . Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020; 323(20):2052-2059. PMC: 7177629. DOI: 10.1001/jama.2020.6775. View

4.
. Geographic Differences in COVID-19 Cases, Deaths, and Incidence - United States, February 12-April 7, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(15):465-471. PMC: 7755058. DOI: 10.15585/mmwr.mm6915e4. View

5.
Vandenberg O, Martiny D, Rochas O, van Belkum A, Kozlakidis Z . Considerations for diagnostic COVID-19 tests. Nat Rev Microbiol. 2020; 19(3):171-183. PMC: 7556561. DOI: 10.1038/s41579-020-00461-z. View